Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis

The estimated attributable mortality rate for invasive candidiasis (IC) in the intensive care unit (ICU) setting varies from 30 to 40%. Physiological changes in critically ill patients may affect the distribution and elimination of micafungin, and therefore, dosing adjustments might be mandatory. Th...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Boonstra, J. M., van der Elst, K. C., Veringa, A., Jongedijk, E. M., Brüggemann, R. J., Koster, R. A., Kampinga, G. A., Kosterink, J. G., van der Werf, T. S., Zijlstra, J. G., Touw, D. J., Alffenaar, J. W. C.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2017
Sujets:
Clinical Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5700342/
https://ncbi.nlm.nih.gov/pubmed/28971861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01398-17
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires